Subsequently, we demonstrated through CCK-8 assays, scratch wound healing assays, and Transwell invasion assays that both IL-17A and IL-26 significantly enhanced the proliferation, migration, and invasive capacities of gastric cancer cells, thereby facilitating gastric cancer progression. The gene discussed is IL26; the disease is gastric cancer.